Organogenesis Holdings (ORGO) Short-term Investments (2017 - 2026)

Organogenesis Holdings' Short-term Investments history runs 10 years deep, the most recent figure standing at $720000.0 for Q1 2026.

• In Q1 2026, Short-term Investments rose 26.54% year-over-year to $720000.0; the TTM figure through Mar 2026 stood at $720000.0 (up 26.54% YoY), while the FY2025 annual figure was $652000.0, up 12.41% from the prior year.
• Short-term Investments was $720000.0 for Q1 2026 at Organogenesis Holdings, up from $652000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $5.3 million in Q2 2025 to a low of $498000.0 in Q4 2023.
• Historically, Short-term Investments has averaged $1.1 million across 5 years, with a median of $652000.0 in 2025.
• The sharpest annual moves came in 2023 and 2025: Short-term Investments tumbled 38.67% in 2023, then soared 819.48% in 2025.
• A 5-year view of Short-term Investments shows it stood at $812000.0 in 2022, then sank by 38.67% to $498000.0 in 2023, then rose by 16.47% to $580000.0 in 2024, then gained by 12.41% to $652000.0 in 2025, then rose by 10.43% to $720000.0 in 2026.
• The last three Short-term Investments figures came in at $720000.0 (Q1 2026), $652000.0 (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.